Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Pacelli

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancers|March 10, 2022
DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and RadiotherapyNghia T Nguyen, Anna Pacelli, Michael Nader, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Fully Automated, High-Dose Radiosynthesis of [<sup>18</sup>F]PARPiAnna Pacelli, Fadi Zarrad, Wolfgang P Fendler, et al.
The Breast Journal|October 23, 2002
Intracystic papillary carcinoma of the breast in a male patient diagnosed by ultrasound-guided core biopsy: a case reportAnna Pacelli, Brian J Bock, Eric A Jensen, et al.
Mayo Clinic Proceedings|December 3, 2010
Primary signet ring cell carcinoma of the prostateJonathan N Warner, Leah Y Nakamura, Anna Pacelli, et al.
Pharmaceutics|July 30, 2025
<sup>68</sup>Ga Extemporaneous Preparations in RadiopharmacyMarzia Rizzello, Anna Pacelli, Maria Domenica De Bari, et al.
The Journal of Urology|August 21, 2002
Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survivalDavid G Bostwick, Junqi Qian, Anna Pacelli, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Correction: Pacelli et al. Fully Automated, High-Dose Radiosynthesis of [18F]PARPi. <i>Pharmaceuticals</i> 2022, <i>15</i>, 865Anna Pacelli, Fadi Zarrad, Corentin Warnier, et al.
BJU International|November 12, 2009
Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 monthsAaron D Martin, Rafael N Nunez, Anna Pacelli, et al.
EJNMMI Research|August 13, 2022
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agentClaudia Rose Fraser, Javier Ajenjo, Mathew Veal, et al.
Molecular Imaging and Biology|April 29, 2020
[<sup>18</sup>F]AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET ImagingFlorian Guibbal, Samantha L Hopkins, Anna Pacelli, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancers|March 10, 2022
DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and RadiotherapyNghia T Nguyen, Anna Pacelli, Michael Nader, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Fully Automated, High-Dose Radiosynthesis of [<sup>18</sup>F]PARPiAnna Pacelli, Fadi Zarrad, Wolfgang P Fendler, et al.
The Breast Journal|October 23, 2002
Intracystic papillary carcinoma of the breast in a male patient diagnosed by ultrasound-guided core biopsy: a case reportAnna Pacelli, Brian J Bock, Eric A Jensen, et al.
Mayo Clinic Proceedings|December 3, 2010
Primary signet ring cell carcinoma of the prostateJonathan N Warner, Leah Y Nakamura, Anna Pacelli, et al.
Pharmaceutics|July 30, 2025
<sup>68</sup>Ga Extemporaneous Preparations in RadiopharmacyMarzia Rizzello, Anna Pacelli, Maria Domenica De Bari, et al.
The Journal of Urology|August 21, 2002
Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survivalDavid G Bostwick, Junqi Qian, Anna Pacelli, et al.
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Correction: Pacelli et al. Fully Automated, High-Dose Radiosynthesis of [18F]PARPi. <i>Pharmaceuticals</i> 2022, <i>15</i>, 865Anna Pacelli, Fadi Zarrad, Corentin Warnier, et al.
BJU International|November 12, 2009
Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 monthsAaron D Martin, Rafael N Nunez, Anna Pacelli, et al.
EJNMMI Research|August 13, 2022
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agentClaudia Rose Fraser, Javier Ajenjo, Mathew Veal, et al.
Molecular Imaging and Biology|April 29, 2020
[<sup>18</sup>F]AZD2461, an Insight on Difference in PARP Binding Profiles for DNA Damage Response PET ImagingFlorian Guibbal, Samantha L Hopkins, Anna Pacelli, et al.
Pageof 2